Podcast

James Matera, DO, on the Renoprotective Effects of SGLT2 Inhibitors in DKD

01/13/2020

Dr Matera reviews recent evidence that has demonstrated the potential renal protection offered by sodium glucose co-transporter 2 inhibitors against diabetic kidney disease.

James Matera, DO, FACOI, is a practicing nephrologist, Senior Vice President for Medical Affairs, and Chief Medical Officer at CentraState Medical Center in Freehold, New Jersey.

References:

  1. HHS launches President Trump’s “advancing American kidney health” initiative [press release]. July 10, 2019. https://www.hhs.gov/about/news/2019/07/10/hhs-launches-president-trump-advancing-american-kidney-health-initiative.html.
  2. Perkovic V, Jardine MJ, Neal B, et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Eng J Med. 2019;380:2295-2306. doi:10.1056/NEJMoa1811744.
  3. Tuttle KR, Lakshmanan MC, Rayner B, et al. Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial. Lancet Diabetes Endocrinol. 2018;6(8):605-617. https://doi.org/10.1016/S2213-8587(18)30104-9.
  4. Walther CP, Richardson P, Winkelmayer WC, et al. ACEi/ARB discontinuation and adverse outcomes in CKD. Presented at: American Society of Nephrology 2019 Kidney Week; November 7, 2019 Washington, DC.

Related Content

Podcasts
Podcasts
Alyssa Vivas, MD, on What Is Causing This Man’s Severe Hyperkeratotic Lower-Extremity Lesions? - Podcast
11/15/2017
<p>The lead author of the November PhotoQuiz, Alyssa Vivas, DO, discusses her case report and the patient's outcome.</p>
11/15/2017
Mental Health
Mental Health
Sanjay J. Matthew, MD, on Ketamine's Mechanism of Action
06/25/2019
In this podcast, Sanjay J. Mathew, MD, discusses how ketamine works in the body and how it is different from other antidepressants.
06/25/2019
HIV Management
HIV Management
Anandi Sheth, MD, MSc, on HIV Prevention in Women
05/20/2020
In this podcast, she discusses HIV prevention for women, specifically cisgender women and other underrepresented women.
05/20/2020
Cardiometabolic Risk
Cardiometabolic Risk
Michael Bloch, MD, on the New "Prehypertension"
06/27/2018
<p>Dr Michael Bloch from Blue Spruce Medical Consultants talks about the ACP's new hypertension guidance, the new "prehypertension" group of patients, and more.</p>
06/27/2018
Gastroenterology
Gastroenterology
Brian Lacy, MD, on Major Advances in Gastroenterology 2010-2019
09/02/2020
He discusses the American Journal of Gastroenterology's recent publication of a review of major advancements in gastroenterology over the previous decade.
09/02/2020